Dr David Williams

CEO Discuva

David has been working in the Pharmaceutical industry for over 30 years, passionately and directly involved in all aspects of drug discovery and development working towards providing treatments for many diseases including new drugs marketed for infectious disease and cancer. Originally in banking, he retrained as a scientist going on to develop distinguished expertise in signal transduction and structural biology research having authored or co-authored over 70 significant publications and patents.  As well as co-founding the successful Antibiotics Company, Discuva, in 2009, David also co-founded the disruptive therapeutics company, Bactevo and the AIM-listed Oncology drug discovery company Sareum and as part of the senior management steered Summit plc back to financial and scientific viability.  Other major roles in UK/US senior management and research were performed at Millennium Pharmaceuticals, Medivir, Acambis and Roche.